通过先进的基因组技术重新定义细胞重编程
Samantha A Morris1,2,3
1Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. samorris2@bwh.harvard.edu.
Nature reviews. Genetics
|October 17, 2025
概括
细胞重编程对医学有希望,但不成熟和低保真度等挑战仍然存在. 新的基因组和计算工具正在揭示如何改进用于疾病建模和治疗的工程细胞.
科学领域:
- 细胞重编程和再生医学
- 基因组技术和计算生物学
背景情况:
- 转录因子介导的重编程 (诱导多能性,定向分化) 为疾病建模和再生医学提供了潜力.
- 当前的重编程方法通常会产生具有不完整分子和功能特征的细胞,表现为不成熟,低保真性和异质性.
- 这些局限性阻碍了工程细胞在疾病建模和治疗应用中的可靠性.
研究的目的:
- 探索最近单细胞基因组学和计算框架的进展如何能够阐明重新编程效率低下的机制.
- 在细胞重编程过程中识别可处理的故障点.
- 引导下一代重编程策略的设计,以提高细胞忠实度,成熟度和纯度.
主要方法:
- 使用单细胞基因组技术来分析细胞异质性和分子形状.
- 应用集成计算框架来分析复杂的基因组数据.
- 采用新兴的分子记录工具来理解重编程动态.
主要成果:
- 最近的技术进步开始揭示不完整或低效的重编程的潜在机制.
- 在重新编程协议中已经确定了特定的故障点.
- 这些见解有助于更深入地了解细胞身份操纵.
结论:
- 先进的基因组和计算工具对于理解和克服重编程限制至关重要.
- 机制引导的协议设计可以导致细胞忠实度,成熟度和纯度的逐步改善.
- 优化的重编程策略有可能将工程细胞推向临床相关性.
相关概念视频
Introduction to Nuclear Reprogramming
2.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K
Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
Somatic to iPS Cell Reprogramming
2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
Chromatin Modification in iPS Cells
2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K
Forced Transdifferentiation
2.3K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
2.3K


